The molecular determinants that render specific populations of normal cells susceptible to oncogenic reprogramming into self-renewing cancer stem cells are poorly understood. Here, we exploit T-cell acute lymphoblastic leukemia (T-ALL) as a model to define the critical initiating events in this disease. First, thymocytes that are reprogrammed by the SCL and LMO1 oncogenic transcription factors into self-renewing pre-leukemic stem cells (pre-LSCs) remain non-malignant, as evidenced by their capacities to generate functional T cells. Second, we provide strong genetic evidence that SCL directly interacts with LMO1 to activate the transcription of a self-renewal program coordinated by LYL1. Moreover, LYL1 can substitute for SCL to reprogram thy...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy largely caused by aberrant a...
The LMO2 oncogene causes a subset of human T cell acute lymphoblastic leukemias (T-ALL), including f...
T cell acute lymphoblastic leukaemia (T-ALL) cases include subfamilies that overexpress the TAL1/LMO...
The molecular determinants that render specific populations of normal cells susceptible to oncogenic...
<div><p>The molecular determinants that render specific populations of normal cells susceptible to o...
The molecular determinants that render specific populations of normal cells susceptible to oncogenic...
International audienceThe molecular determinants that render specific populations of normal cells su...
International audienceThe molecular determinants that render specific populations of normal cells su...
International audienceThe molecular determinants that render specific populations of normal cells su...
International audienceThe molecular determinants that render specific populations of normal cells su...
T cell acute lymphoblastic leukemia (T-ALL) develops in a multistep process whereby thymic progenito...
Lmo2 is an oncogenic transcription factor that is frequently overexpressed in T-cell acute lymphobla...
Leukemia initiating cells (LIC) contribute to therapeutic resistance through acquisition of mutation...
Lmo2 is an oncogenic transcription factor that is frequently overexpressed in T-cell acute lymphobla...
<div><h3>Background</h3><p>Leukemia initiating cells (LIC) contribute to therapeutic resistance thro...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy largely caused by aberrant a...
The LMO2 oncogene causes a subset of human T cell acute lymphoblastic leukemias (T-ALL), including f...
T cell acute lymphoblastic leukaemia (T-ALL) cases include subfamilies that overexpress the TAL1/LMO...
The molecular determinants that render specific populations of normal cells susceptible to oncogenic...
<div><p>The molecular determinants that render specific populations of normal cells susceptible to o...
The molecular determinants that render specific populations of normal cells susceptible to oncogenic...
International audienceThe molecular determinants that render specific populations of normal cells su...
International audienceThe molecular determinants that render specific populations of normal cells su...
International audienceThe molecular determinants that render specific populations of normal cells su...
International audienceThe molecular determinants that render specific populations of normal cells su...
T cell acute lymphoblastic leukemia (T-ALL) develops in a multistep process whereby thymic progenito...
Lmo2 is an oncogenic transcription factor that is frequently overexpressed in T-cell acute lymphobla...
Leukemia initiating cells (LIC) contribute to therapeutic resistance through acquisition of mutation...
Lmo2 is an oncogenic transcription factor that is frequently overexpressed in T-cell acute lymphobla...
<div><h3>Background</h3><p>Leukemia initiating cells (LIC) contribute to therapeutic resistance thro...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy largely caused by aberrant a...
The LMO2 oncogene causes a subset of human T cell acute lymphoblastic leukemias (T-ALL), including f...
T cell acute lymphoblastic leukaemia (T-ALL) cases include subfamilies that overexpress the TAL1/LMO...